CREBL2

gene product
cAMP response element (CRE)-binding protein-like-2 (CREBL2) was identified in a search to find genes in a commonly deleted region on chromosome 12p13 flanked by ETV6 and CDKN1B genes, frequently associated with hematopoietic malignancies, as well as breast, non-small-cell lung and ovarian cancers. CREBL2 shares a 41% identity with CRE-binding protein (CREB) over a 48-base long region which encodes the bZip domain of CREB. The bZip domain consists of about 30 amino acids rich in basic residues involved in DNA binding, followed by a leucine zipper motif involved in protein dimerization. This suggests that CREBL2 encodes a protein with DNA binding capabilities. The occurance of CREBL2 deletion in malignancy suggests that CREBL2 may act as a tumor suppressor gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
63 antibodies from 14 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
4 antibodies
antibodies-online
17 antibodies
Abnova Corporation
6 antibodies
LifeSpan BioSciences, Inc.
15 antibodies
Atlas Antibodies
1 antibody
Invitrogen Antibodies
1 antibody
NovoPro Bioscience Inc.
1 antibody
Acris Antibodies GmbH
2 antibodies
Proteintech Group
1 antibody
Biorbyt
5 antibodies
RabMAbs
1 antibody
Creative Biolabs
4 antibodies
Creative Diagnostics
3 antibodies
MyBioSource
2 antibodies